Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zalypsis in advanced endometrial or cervical cancer
NCT00900562Phase 2Terminated
- Sponsor
- PharmaMar
- Start
- Aug 2009
- Primary completion
- Sep 2011
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of zalypsis in endometrial cancer (EC), Cervical Cancer (CC), sponsored by PharmaMar. Started Aug 2009; status: terminated.
02
Drugs
zalypsis
03
Conditions
endometrial cancer (EC)Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00900562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00900562.